Market News AIOpen the app

Akari Therapeutics Plc has new directors and officers, plus changes to pay for some leaders (AKTX).

New bossRead the original at SEC EDGAR
Bad for AKTX

Akari raised its CEO's salary and bonus target and granted share awards, increasing pay costs and possible share issuance. Some pay is in shares, and awards need shareholder approval, but that does not erase the higher pay.

AKTX · Akari Therapeutics Plc

AI read · Bad for AKTX

The AI's read

The higher salary and bonus target mean Akari will pay its CEO more. The share awards could add shares if shareholders approve a larger share reserve. Paying part of the salary in shares saves cash, but does not erase the higher pay. If approval fails, Akari must make cash adjustment payments.

Get alerts for AKTX

Follow Akari Therapeutics Plc (AKTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AKTX
Free on the App Store and Google Play, or on the web.